Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNCPM 22120 5-FU Study
PACTR202401582817992Phase 1Unknown
- Sponsor
- UNC Department of Obstetrics and Gynecology
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fluorouracil in cervical intraepithelial neoplasia (CIN), sponsored by UNC Department of Obstetrics and Gynecology. Primary endpoint: Safety. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on PACTR202401582817992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401582817992.